Sage Therapeutics Inc. pushed off questions about potential mergers or acquisitions during its first earnings call since ...

Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the embattled biotech at just $469 million.

Since then, Biogen decided to opt out of their partnership on essential tremor candidate SAGE-324 after disappointing results ...

The Tyneside-based FTSE100 firm issued first quarter trading results for the three months to the end of December which showed ...

The proposed merger of the two Cambridge drugmakers is off, but Sage says it's open to "strategic alternatives" — including a sale. Sage Therapeutics Inc. is looking for a deal — but it’s ...

In a report released on January 30, Florian Treisch from Kepler Capital maintained a Buy rating on Sage Group plc (SGE – Research Report), ...

AUSTIN, Texas--(BUSINESS WIRE)--Blue Sage Capital, a leading lower-middle market private equity firm, today announced the final close of Blue Sage Capital IV, L.P. (the “Fund”), at $618 ...

Business Insider's personal finance team compared Sage Mortgage to the best mortgage lenders and found it to be a standard lender Sage Mortgage has loan options that should meet most borrowers ...

Britain's Sage Group on Thursday maintained its full-year forecasts after the software firm posted a 10 per cent growth in ...